ATHE:Sponsored ADR (New)/Alterity Therapeutics Ltd - Stock Price Quote and Dividend Data
ATHE STOCK PRICE LATEST CLOSE
$2.86
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Biotechnology
Sponsored ADR (New)/Alterity Therapeutics Ltd Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Split Payment TypeReverse Split
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
Sponsored ADR (New)/Alterity Therapeutics Ltd Stock Price Information
52-Week Low/High Stock Price$1.00 - $5.87
Percent Held by Institutions0.59%
Revenue$268,419
Net Income$-19,123,464
Cash Flow$-12,605,824
EPS0.00%
Market Cap$279,917
PE Ratio to Industry40%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.42%
Total Return Last 12 Months30.42%
Total Return Last 3 Years-64.30%
Total Return Last 5 Years-54.66%
Latest Trade DateApr. 10, 2025
Sponsored ADR (New)/Alterity Therapeutics Ltd Annual Stock Dividends
No Data available for Payment History.
Sponsored ADR (New)/Alterity Therapeutics Ltd Dividend Payment History
| No dividends retrieved for ATHE |
Sponsored ADR (New)/Alterity Therapeutics Ltd Other Dividend Details
Alterity Therapeutics is a development stage enterprise engaged in the research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's disease, Huntington disease, Parkinson's disease and other neurological disorders. Co. is developing therapies to treat neurodegenerative diseases. Co.'s primary drug candidate, ATH434 is for treatment of Parkinson's disease. Other applications for Co.'s main compounds include the treatment or amelioration of neurodegenerative disorders such as tauopathies, Motor Neuron disease, Creutzfeldt-Jakob disease, certain cancers, age-related macular degeneration, or antibiotic resistance.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Jan. 31, 2025ATHE STOCK PRICE INCREASE: Sponsored ADR (New)/Alterity Therapeutics Ltd on 01-31-2025 increased stock price > 10% from $2.91 to $4.57
Jan. 25, 2025ATHE STOCK PRICE DECREASE: Sponsored ADR (New)/Alterity Therapeutics Ltd on 01-25-2025 decreased stock price > 10% from $3.34 to $2.94
Jan. 09, 2025ATHE STOCK PRICE DECREASE: Sponsored ADR (New)/Alterity Therapeutics Ltd on 01-09-2025 decreased stock price > 10% from $3.72 to $3.34
Jan. 04, 2025ATHE STOCK PRICE INCREASE: Sponsored ADR (New)/Alterity Therapeutics Ltd on 01-04-2025 increased stock price > 10% from $3.73 to $4.26
Jan. 03, 2025ATHE STOCK PRICE INCREASE: Sponsored ADR (New)/Alterity Therapeutics Ltd on 01-03-2025 increased stock price > 10% from $3.31 to $3.73
Dec. 31, 2024ATHE STOCK PRICE INCREASE: Sponsored ADR (New)/Alterity Therapeutics Ltd on 12-31-2024 increased stock price > 10% from $3.14 to $3.50
Dec. 27, 2024ATHE STOCK PRICE INCREASE: Sponsored ADR (New)/Alterity Therapeutics Ltd on 12-27-2024 increased stock price > 10% from $2.45 to $3.15
Dec. 10, 2024ATHE STOCK PRICE INCREASE: Sponsored ADR (New)/Alterity Therapeutics Ltd on 12-10-2024 increased stock price > 10% from $2.15 to $2.48
Dec. 07, 2024ATHE STOCK PRICE INCREASE: Sponsored ADR (New)/Alterity Therapeutics Ltd on 12-07-2024 increased stock price > 10% from $1.94 to $2.15
Dec. 05, 2024ATHE STOCK PRICE INCREASE: Sponsored ADR (New)/Alterity Therapeutics Ltd on 12-05-2024 increased stock price > 10% from $1.60 to $1.88
Apr. 11, 2025DIVIDEND RATE INCREASE: ADR (Sponsored)/CSL Ltd (OTCBB: CSLLY) on 04-11-2025 increased dividend rate > 3% from $1.22 to $1.28
Apr. 11, 2025KRBPQ STOCK PRICE DECREASE: Kiromic BioPharma Inc on 04-11-2025 decreased stock price > 10% from $0.12 to $0.08
Apr. 11, 2025OMGAQ STOCK PRICE DECREASE: Omega Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $0.05 to $0.04
Apr. 11, 2025ALGS STOCK PRICE DECREASE: Aligos Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $5.03 to $3.99
Apr. 11, 2025ATRA STOCK PRICE DECREASE: Atara Biotherapeutics Inc on 04-11-2025 decreased stock price > 10% from $5.89 to $5.30
Apr. 11, 2025ZVSA STOCK PRICE DECREASE: Com Par $0.001/ZyVersa Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $1.03 to $0.77
Apr. 11, 2025GERNW STOCK PRICE DECREASE: Wt Pur Com Exp 12/31/2025/Geron Corp. on 04-11-2025 decreased stock price > 10% from $0.30 to $0.27
Apr. 11, 2025RVMDW STOCK PRICE DECREASE: Wt Exp/Revolution Medicines Inc on 04-11-2025 decreased stock price > 10% from $0.05 to $0.03
Apr. 11, 2025ELUT STOCK PRICE DECREASE: Cl A Com/Elutia Inc on 04-11-2025 decreased stock price > 10% from $2.49 to $2.24
Apr. 11, 2025QNRX STOCK PRICE DECREASE: Sponsored ADR (New)/Quoin Pharmaceuticals Ltd on 04-11-2025 decreased stock price > 10% from $6.89 to $5.49
